NR4A1 and dementia: Androgen deprivation therapy was linked to an increased risk for ADRD in two studies by the same team.82, 83 However, aromatase inhibitor therapy and tamoxifen, used for hormone receptor-positive breast cancer, did not show a difference in dementia risk.84